Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous HPV-specific cytotoxic T lymphocytes

A population of autologous cytotoxic T lymphocytes (CTLs) that are specifically reactive to human papillomavirus (HPV), with potential antiviral and antineoplastic activities. Upon infusion of the autologous HPV-specific CTLs, these CTLs induce selective toxicity in HPV-positive cancer cells and other HPV-infected cells. HPV is associated with various cancer cell types.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	autologous HPV-specific immune lymphocytes
Abbreviation:	autologous HPV-CTLs

autologous HPV-specific cytotoxic T lymphocytes

Search NCI's Drug Dictionary